摘要 |
The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving 5-HT2A receptor, serotonin transporter (SERT) and/or pathways involving dopamine D2 receptor signaling systems.. |
申请人 |
INTRA-CELLULAR THERAPIES, INC |
发明人 |
MATES, SHARON;DAVIS, ROBERT;LI, PENG;WENNOGLE, LAWRENCE;LERNER, RICHARD A. |